Crouse Steven C. 4

4 · BIO-TECHNE Corp · Filed Mar 4, 2026

Insider Transaction Report

Form 4

Period: 2026-03-02

BIO-TECHNE CorpTECH

Crouse Steven C.

President - Diag & Spatial Bi

Transactions

Award
Performance Restricted Stock Units
[F1][F14]
2026-03-02+2,387→ 2,387 total
→ Common Stock (2,387 underlying)
Award
Restricted Stock Units
[F1][F15]
2026-03-02+735→ 735 total
→ Common Stock (735 underlying)
Award
Stock Option (right to buy)
[F16]
2026-03-02+1,911→ 1,911 total
Exercise: $57.82Exp: 2036-03-02→ Common Stock (1,911 underlying)

Holdings

Common Stock
5,894
Restricted Stock Units
[F1][F2]
→ Common Stock (1,588 underlying)
1,588
Restricted Stock Units
[F1][F3]
→ Common Stock (1,800 underlying)
1,800
Restricted Stock Units
[F1][F4]
→ Common Stock (1,379 underlying)
1,379
Restricted Stock Units
[F1][F5]
→ Common Stock (3,737 underlying)
3,737
Restricted Stock Units
[F1][F6]
→ Common Stock (6,529 underlying)
6,529
Stock Option (right to buy)
[F7]
Exercise: $97.13Exp: 2028-04-01→ Common Stock (3,856 underlying)
3,856
Stock Option (right to buy)
[F7]
Exercise: $120.46Exp: 2028-08-06→ Common Stock (19,032 underlying)
19,032
Stock Option (right to buy)
[F8]
Exercise: $94.52Exp: 2029-08-15→ Common Stock (24,560 underlying)
24,560
Stock Option (right to buy)
[F9]
Exercise: $84.61Exp: 2030-08-15→ Common Stock (12,649 underlying)
12,649
Stock Option (right to buy)
[F10]
Exercise: $73.46Exp: 2031-05-01→ Common Stock (7,327 underlying)
7,327
Stock Option (right to buy)
[F11]
Exercise: $74.91Exp: 2034-08-15→ Common Stock (17,133 underlying)
17,133
Stock Option (right to buy)
[F12]
Exercise: $48.61Exp: 2035-06-02→ Common Stock (5,434 underlying)
5,434
Stock Option (right to buy)
[F13]
Exercise: $53.60Exp: 2035-08-15→ Common Stock (19,151 underlying)
19,151

Footnotes (16)

[F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
[F10]Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027.
[F11]Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026.
[F12]Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029.
[F13]Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028.
[F14]Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F15]245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029.
[F16]Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029.
[F2]794 restricted stock units vest on 5/1/2026 and 5/1/2027.
[F3]600 restricted stock units vest on each of 6/2/2026, 6/2/2027 and 6/2/2028.
[F4]1,379 restricted stock units vest on 8/15/2026.
[F5]1,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027.
[F6]2,176 restricted stock units vest on each of 8/15/2026 and 8/15/2028; and 2,177 restricted stock units vest on 8/15/2027.
[F7]100% vested.
[F8]Options to purchase 6,140 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
[F9]Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025.

Signature

/s/ Andrew Nick as Attorney-in-Fact for Steven C. Crouse pursuant to Power of Attorney previously filed.|2026-03-04

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES